HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis
Daniela Tudor(Délégation Paris 5), Morgane Bomsel(Centre National de la Recherche Scientifique), Mehdi Houimel(Centre National de la Recherche Scientifique), Lorenzo Diomede(Vita-Salute San Raffaele University), Christiane Moog(Inserm), Lucia Lopalco(Vita-Salute San Raffaele University), A-S Drillet(Centre National de la Recherche Scientifique), Muriel Derrien(Rega Institute for Medical Research)
Cited by 140
Related Papers
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244